$INAB
In8bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
INAB chart
What traders are saying about $INAB
Latest postsIn8bio, Inc. news
- Weekly Recap: Zero Q3 revenue and INB-400 enrollment suspended
TradingView ·
- IN8bio Inc (6JH0.SG) Seasonal returns chart
Yahoo Finance Australia ·
- In8bio, Inc. Confronts Rising Social Media, AI, and Cyber Risk to Reputation and Competitive Edge
TipRanks ·
- JonesTrading Maintains In8bio(INAB.US) With Buy Rating, Maintains Target Price $5
Moomoo ·
- IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- A new hire can earn the right to buy IN8bio shares over four years.
Stock Titan ·
- IN8bio, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- IN8bio 3Q 2026: EPS ($0.24) — 10-Q Summary
TradingView ·
- With $14M in cash, IN8BIO (INAB) flags substantial doubt about its ability to continue.
Stock Titan ·
- IN8bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- Press Release: IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Moomoo ·
In8bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$19.4M | -$30.4M | -$30.0M | -$28.5M |
| Diluted EPS | $-4.44 | $-17.05 | $-1.00 | $-1.36 |
| Total assets (year end) | $32.3M | $20.9M | $33.7M | $33.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About In8bio, Inc.
- Ticker
- INAB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1740279
- Former names
- Incysus Therapeutics, Inc.
Frequently asked questions
What exchange is In8bio, Inc. listed on?
In8bio, Inc. trades on the Nasdaq under the ticker symbol INAB.
What industry is In8bio, Inc. in?
In8bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is In8bio, Inc. headquartered?
In8bio, Inc.'s business address on file with the SEC is in New York, NY.
When does In8bio, Inc.'s fiscal year end?
In8bio, Inc.'s fiscal year ends on December 31.